Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-17-007162
Filing Date
2017-11-17
Accepted
2017-11-17 16:10:49
Documents
4
Period of Report
2017-12-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2233878zpre14a.htm PRE 14A 414235
2 G729873.JPG g729873.jpg GRAPHIC 19757
3 G272072BCI001.GIF g272072bci001.gif GRAPHIC 156509
4 G272072BEI001.GIF g272072bei001.gif GRAPHIC 68222
  Complete submission text file 0001047469-17-007162.txt   752440
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: PRE 14A | Act: 34 | File No.: 001-37418 | Film No.: 171211052
SIC: 2834 Pharmaceutical Preparations